CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein (Q43690717)

25 November 2017

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein (English)

1 reference

respiratory syncytial virus

25 November 2017

0 references

RSV major surface glycoprotein G

0 references

modulation by virus of host process

0 references

modulation by host of viral process

0 references

6

Anderson LJ

1 reference

25 November 2017

3

Haynes LM

1 reference

25 November 2017

Tripp RA

1

1 reference

25 November 2017

Jones LP

series ordinal

2

1 reference

25 November 2017

Zheng H

series ordinal

4

1 reference

25 November 2017

Murphy PM

series ordinal

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

25 November 2017

1 reference

25 November 2017

2

1 reference

25 November 2017

732-738

1 reference

25 November 2017

8

1 reference

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

25 November 2017

1 reference

7 January 2021

Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.

1 reference

7 January 2021

Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia

1 reference

7 January 2021

Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity

1 reference

7 January 2021

Comparison of the T helper cell response induced by respiratory syncytial virus and its fusion protein in BALB/c mice

1 reference

7 January 2021

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

1 reference

7 January 2021

Immunity and immunopathology to respiratory syncytial virus. The mouse model

1 reference

7 January 2021

Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge

1 reference

7 January 2021

Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus

1 reference

7 January 2021

Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.

1 reference

7 January 2021

Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus

1 reference

7 January 2021

Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse

1 reference

7 January 2021

Differential binding of chemokines to glycosaminoglycan subpopulations

1 reference

7 January 2021

Macrophage inflammatory proteins: biology and role in pulmonary inflammation

1 reference

7 January 2021

The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines

1 reference

7 January 2021

The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins

1 reference

7 January 2021

Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein

1 reference

7 January 2021

Chemokines and their receptors in infectious disease

1 reference

7 January 2021

Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes

1 reference

7 January 2021

The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8

1 reference

7 January 2021

Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1

1 reference

7 January 2021

Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies

1 reference

7 January 2021

Antigenic analysis of chimeric and truncated G proteins of respiratory syncytial virus

1 reference

7 January 2021

Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine

1 reference

7 January 2021

Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection

1 reference

7 January 2021

Fractalkine--a strange attractor in the chemokine landscape

1 reference

7 January 2021

Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow

1 reference

7 January 2021

Chemokine receptor trafficking and viral replication

1 reference

7 January 2021

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

1 reference

7 January 2021

The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate

1 reference

7 January 2021

Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice

1 reference

7 January 2021

The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes

1 reference

7 January 2021

Identifiers

DOI

10.1038/90675

1 reference

25 November 2017

1 reference